A major limitation of circulating tumor DNA (ctDNA) for somatic mutation detection has been the low level of ctDNA found in a subset of cancer patients...
Read More »
Novel urine-based test demonstrates ability to accurately predict high-grade prostate cancer; holds potential to advance new prognostic paradigm, reduce unnecessary tissue biopsies NEW ORLEANS, La., and CAMBRIDGE, Mass.–(BUSINESS WIRE)–Exosome Diagnostics, Inc., a developer of revolutionary, biofluid-based molecular diagnostics, today announced ...
Read More »
To discover accurate exosome biomarkers for any pathology, the best biomarkers are always derived from top-quality RNA or peptide libraries. SBI has developed kits that are specifically developed to generate high-quality NGS and Mass Spec libraries. The XRNA kit generates ...
Read More »
Exosome RNA Exosome RNA Research & Industry News
